Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Kay, Jonathan
One or more keywords matched the following items that are connected to Kay, Jonathan
Item TypeName
Academic Article Musculoskeletal manifestations in beta 2-microglobulin amyloidosis. Case discussion.
Academic Article Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
Academic Article Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: a randomized, double-blind, placebo-controlled, dose-ranging study.
Academic Article Imatinib mesylate treatment of nephrogenic systemic fibrosis.
Academic Article A rheumatology-specific informatics-based application with a disease activity calculator.
Academic Article Physician ability to assess rheumatoid arthritis disease activity using an electronic medical record-based disease activity calculator.
Academic Article E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy.
Academic Article Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Academic Article Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention.
Academic Article Golimumab: A novel human anti-TNF-alpha monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.
Academic Article The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I.
Academic Article The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.
Academic Article Golimumab in patients with active rheumatoid arthritis who have previous experience with tumour necrosis factor inhibitors: results of a long-term extension of the randomised, double-blind, placebo-controlled GO-AFTER study through week 160.
Academic Article Evolution of treatment for rheumatoid arthritis.
Academic Article Relapsing polychondritis.
Academic Article 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Academic Article 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.
Academic Article Diabetes mellitus and insulin resistance in patients with rheumatoid arthritis: risk reduction in a chronic inflammatory disease.
Academic Article Biosimilars: a regulatory perspective from America.
Academic Article Assessment of control of rheumatoid arthritis disease activity.
Academic Article ACR/EULAR 2010 rheumatoid arthritis classification criteria.
Academic Article Rheumatoid arthritis: erosion defined: back to basics.
Academic Article The effect of golimumab on haemoglobin levels in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Academic Article Biosimilars to treat inflammatory arthritis: the challenge of proving identity.
Concept Arthritis, Rheumatoid
Concept Arthritis, Psoriatic
Concept Arthritis
Academic Article Methotrexate: the gold standard without standardisation.
Academic Article Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA).
Academic Article Treating rheumatoid arthritis to target: an international initiative.
Academic Article Erratum to: Treating rheumatoid arthritis to target: an international initiative.
Academic Article Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year.
Academic Article Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study.
Academic Article Golimumab 3-year safety update: an analysis of pooled data from the long-term extensions of randomised, double-blind, placebo-controlled trials conducted in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
Academic Article Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor a inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study.
Academic Article Quality indicators in rheumatoid arthritis: results from the METEOR database.
Academic Article Assessment of Global Disease Activity in Rheumatoid Arthritis by Patients and Physicians: Differences Across Countries in the METEOR Database.
Academic Article Validation of a screening instrument for nephrogenic systemic fibrosis.
Academic Article Brief Report: Development and Validation of a Semiautomated Method to Measure Erosion Volume in Inflammatory Arthritis by Computed Tomography Scanning.
Academic Article Editorial: Biosimilars: New or D?j? Vu?
Academic Article Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial.
Academic Article Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Academic Article Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy.
Academic Article Clinical trials of biosimilars should become more similar.
Academic Article Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis.
Academic Article Biosimilars: implications for rheumatoid arthritis therapy.
Academic Article Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial.
Academic Article Reply.
Academic Article Effects of Teriparatide on Joint Erosions in Rheumatoid Arthritis: A Randomized Controlled Trial.
Academic Article The Science Behind Biosimilars: Entering a New Era of Biologic Therapy.
Academic Article Patient Concerns and Perceptions Regarding Biologic Therapies in Ankylosing Spondylitis: Insights From a Large-Scale Survey of Social Media Platforms.
Academic Article A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis.
Academic Article The "Treat to Target" Approach to Rheumatoid Arthritis.
Academic Article Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis.
Academic Article Physical activity and attitudes and perceptions towards physical activity in patients with spondyloarthritis: A systematic review.
Academic Article Overcoming barriers to biosimilars in inflammatory arthritis.
Academic Article The role of interleukin-1 in the pathogenesis of rheumatoid arthritis.
Academic Article The safety of emerging biosimilar drugs for the treatment of rheumatoid arthritis.
Academic Article Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.
Academic Article Synovial fluid eosinophilia in Lyme disease.
Academic Article Identification and characterization of opsonic fibronectin in synovial fluids of patients with active rheumatoid arthritis.
Academic Article Utility of high-resolution ultrasound for the diagnosis of dialysis-related amyloidosis.
Academic Article Biosimilar Uptake in Academic and Veterans Health Administration Settings: Influence of Institutional Incentives.
Academic Article Changes in selected haematological parameters associated with JAK1/JAK2 inhibition observed in patients with rheumatoid arthritis treated with baricitinib.
Academic Article Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial.
Academic Article Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study.
Academic Article Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis.
Academic Article Comanagement with rheumatology and prescription biologics filled during pregnancy in women with rheumatic diseases: a retrospective analysis of US administrative claims data.
Academic Article Use of multibiomarker disease activity scores in biosimilarity studies for the treatment of patients with rheumatoid arthritis.
Academic Article Postpartum Depression in Reproductive-Age Women With and Without Rheumatic Disease: A Population-Based Matched Cohort Study.
Academic Article Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023.
Academic Article Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
Academic Article Sex Differences in Time to Initiate Nonsteroidal Anti-Inflammatory Drugs or Biologic Disease-Modifying Antirheumatic Drugs Among Patients With Axial Spondyloarthritis.
Academic Article American College of Rheumatology and Food and Drug Administration Summit: Summary of the Meeting, May 17-18, 2022.
Search Criteria
  • Arthritis